@article {Raahimie240178, author = {Mina M Raahimi and Alice Kane and Christopher EG Moore and Ahmad W Alareed}, title = {Late onset of Guillain-Barr{\'e} syndrome following SARS-CoV-2 infection: part of {\textquoteleft}long COVID-19 syndrome{\textquoteright}?}, volume = {14}, number = {1}, elocation-id = {e240178}, year = {2021}, doi = {10.1136/bcr-2020-240178}, publisher = {BMJ Specialist Journals}, abstract = {We describe a case of delayed onset, acute demyelinating neuropathy secondary to novel SARS-CoV-2 infection. A previously healthy 46-year-old man presented with bilateral leg pain and loss of sensation in his feet 53 days after having COVID-19 pneumonitis. He developed painful sensory symptoms followed by a rapidly progressive lower motor neuron weakness involving all limbs, face and respiratory muscles, needing ventilatory support. In keeping with a diagnosis of Guillain-Barr{\'e} syndrome, cerebrospinal fluid examination showed albuminocytologic dissociation and nerve conduction studies supported the diagnosis of an acute inflammatory demyelinating polyradiculoneuropathy. The delayed neurological dysfunction seen in our patient following SARS-CoV-2 infection may indicate a novel mechanism of disease that is part of the emerging {\textquoteleft}long COVID-19 syndrome{\textquoteright}.}, URL = {https://casereports.bmj.com/content/14/1/e240178}, eprint = {https://casereports.bmj.com/content/14/1/e240178.full.pdf}, journal = {BMJ Case Reports CP} }